DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14308598

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a dosing regimen for a selective S1P1 receptor agonist, whereby the selective S1P1 receptor agonist is administered to a subject in such a way that during the initial treatment phase the selective S1P1 receptor agonist is administered at a dose which induces desensitization of the heart wherein said dose is below the target dose, and at a dosing frequency that sustains desensitization of the heart, until no further acute heart rate reduction occurs, followed by dose up-titration to the target dose of the selective S1P1 receptor agonist.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ACTELION PHARMACEUTICALS LTDGEWERBESTRASSE 16 ALLSCHWIL 4123

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BROSSARD, Patrick Allschwil, CH 6 67
DINGEMANSE, Jasper Allschwil, CH 13 75
NAYLER, Oliver Arlesheim, CH 51 662
SCHERZ, Michael Ettingen, CH 30 347
STEINER, Beat Dornach, CH 38 534

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation